Select language

Castro Domínguez Francisco

Reumatología

Our services

Terapias biológicas

Las terapias biológicas y celulares son una opción de tratamiento para diversas enfermedades reumáticas, incluyendo la artritis reumatoide, la espondilitis anquilosante y la psoriasis.

Las terapias biológicas implican el uso de proteínas producidas por el cuerpo humano o por ingeniería genética para bloquear o reducir la acción de los mediadores inflamatorios en el cuerpo. Estas proteínas pueden incluir anticuerpos monoclonales, receptores de células T modificados y moléculas de fusión de proteínas. Las terapias biológicas pueden ayudar a reducir la inflamación, mejorar la función articular y prevenir la progresión de la enfermedad.

Request for visit

Name

Surname

Date of Birth

Telephone number

E-mail

Time at which should be contacted

Motivo de su consulta

How did you know about us?

Health insurance

I want to receive information and news from Centro Médico Teknon by e-mail

I understand and accept the privacy notice

Deseo recibir noticias y recomendaciones de salud de los especialistas de Centro Médico Teknon

User Agent

Result email

titulo

The reason for this appointment is due to...

Adalimumab
Adalimumab is a biologic drug belonging to the class of tumor necrosis factor-alpha (TNF-α) inhibitors. In rheumatology, it is primarily used for the treatment of various autoimmune and autoinflammatory diseases, particularly in cases where there is a component of chronic inflammation mediated by TNF-α.
Etanercept
Etanercept is a biologic drug that acts as a soluble TNF receptor fusion protein. It binds to TNF-alpha and prevents it from interacting with cell surface TNF receptors, thereby inhibiting the biological activity of TNF-alpha. In rheumatology, etanercept is primarily used for the treatment of various autoimmune and inflammatory conditions where TNF-alpha plays a central role in disease pathogenesis.
Golimumab
Golimumab is a biologic drug that belongs to the class of tumor necrosis factor-alpha (TNF-α) inhibitors. It works by binding to soluble and membrane-bound TNF-α, thereby inhibiting its interaction with TNF receptors and reducing inflammation. In rheumatology, golimumab is primarily used for the treatment of various autoimmune and inflammatory diseases where TNF-α plays a pivotal role in the disease process.
Tofacitinib
Tofacitinib is a small molecule Janus kinase (JAK) inhibitor that modulates intracellular signaling pathways involved in the inflammatory process. In rheumatology, tofacitinib is primarily used for the treatment of autoimmune diseases, particularly those involving chronic inflammation and joint damage.
Baricitinib
Baricitinib is a small molecule Janus kinase (JAK) inhibitor that works by selectively inhibiting JAK1 and JAK2, key enzymes involved in the signaling pathways of multiple cytokines implicated in the pathogenesis of autoimmune diseases. In rheumatology, baricitinib is primarily used for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded adequately to, or are intolerant of, methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Secukinumab
Secukinumab is a fully human monoclonal IgG1/κ antibody that selectively binds and neutralizes a proinflammatory cytokine, interleukin 17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of autoimmune diseases. In rheumatology, secukinumab is primarily used for the treatment of ankylosing spondylitis and psoriatic arthritis, both of which are chronic inflammatory conditions associated with IL-17A-mediated inflammation.
Ixekizumab
Ixekizumab is an IgG4 type monoclonal antibody that binds with high affinity and specifically to interleukin 17A (both IL-17A and IL-17A/F), a pro-inflammatory cytokine involved in the pathogenesis of autoimmune diseases. In rheumatology, ixekizumab is primarily used for the treatment of psoriatic arthritis, a chronic inflammatory arthritis associated with psoriasis.

Contact us

Centro Médico Teknon

Castro Domínguez Francisco

Consultorios Marquesa (Despacho 53. 3ª Planta)

Marquesa de Vilallonga, 12

08017 Barcelona

+34 611 78 72 40

info@artrotek.org

Schedules

	Morning	Afternoon
Monday	08:00 - 14:00 h	15:00 - 20:00 h
Tuesday	08:00 - 14:00 h	15:00 - 20:00 h
Wednesday	08:00 - 14:00 h	15:00 - 20:00 h
Thursday	08:00 - 14:00 h	15:00 - 20:00 h
Friday	08:00 - 14:00 h	15:00 - 20:00 h

Carrer de Vilana, 12, 08022 Barcelona

932 906 200